| Title | Molecular Neurodegeneration |
| Abbreviation | Mol. Neurodegener. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Neurology (clinical) (Q1) |
| h-index | 103 |
| Overall Rank/Ranking | 253 |
| SCImago Journal Rank (SJR) | 5.158 |
| Impact Score | 13.63 |
| Publisher | BioMed Central Ltd. |
| Country | United Kingdom |
| ISSN | 17501326 |
| Best Quartile | Q1 |
| Coverage History | 2006-2022 |
Molecular Neurodegeneration is an open access, peer-reviewed online journal that will encompass all aspects of neurodegeneration research at the molecular and cellular levels.
Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer"s disease, Parkinson disease, Huntington disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger.
Molecular Neurodegeneration is a journal covering the technologies/fields/categories related to Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Neurology (clinical) (Q1). It is published by BioMed Central Ltd.. The overall rank of Molecular Neurodegeneration is 253. According to SCImago Journal Rank (SJR), this journal is ranked 5.158. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 103. The best quartile for this journal is Q1.
The ISSN of Molecular Neurodegeneration journal is 17501326. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Neurodegeneration is cited by a total of 3203 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Molecular Neurodegeneration is 13.63, which is computed in 2023 as per its definition. Molecular Neurodegeneration IF is decreased by a factor of 3.13 and approximate percentage change is -18.68% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Molecular Neurodegeneration is 13.63. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 13.63 |
| 2021 | 16.76 |
| 2020 | 12.10 |
| 2019 | 9.31 |
| 2018 | 8.21 |
| 2017 | 6.78 |
| 2016 | 7.32 |
| 2015 | 6.85 |
| 2014 | 7.01 |
Molecular Neurodegeneration has an h-index of 103. It means 103 articles of this journal have more than 103 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Molecular Neurodegeneration is 17501326. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Molecular Neurodegeneration is 253. According to SCImago Journal Rank (SJR), this journal is ranked 5.158. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5.158 |
| 2021 | 4.731 |
| 2020 | 5.565 |
| 2019 | 4.040 |
| 2018 | 3.988 |
| 2017 | 3.418 |
| 2016 | 3.684 |
| 2015 | 3.636 |
| 2014 | 3.315 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 253 |
| 2021 | 295 |
| 2020 | 240 |
| 2019 | 376 |
| 2018 | 409 |
| 2017 | 514 |
| 2016 | 463 |
| 2015 | 455 |
| 2014 | 550 |
Molecular Neurodegeneration is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Molecular Neurodegeneration is Mol. Neurodegener.. This abbreviation ('Mol. Neurodegener.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Neurology (clinical) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Molecular Neurodegeneration latest impact IF is 13.63. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 16.76 (2021) and 6.78 (2017), respectively, in the last 9 years. Moreover, its average IS is 9.77 in the previous 9 years.
The Molecular Neurodegeneration has an SJR (SCImago Journal Rank) of 5.158, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 5.565 in 2020 and the lowest being 3.315 in 2014. Furthermore, the average SJR of the Molecular Neurodegeneration over the previous 9-year period stands at 9.77.
The latest h-index of the Molecular Neurodegeneration is 103.
The Molecular Neurodegeneration is published by the BioMed Central Ltd., with its country of publication being the United Kingdom.
The Molecular Neurodegeneration is currently ranked 253 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 240 in 2020 and its lowest position of 550 in 2014.
The standard ISO4 abbreviation for the Molecular Neurodegeneration is Mol. Neurodegener..
Molecular Neurodegeneration is classified as a journal that the BioMed Central Ltd. publishes.
The Molecular Neurodegeneration encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Molecular Neurodegeneration is assigned the following International Standard Serial Numbers (ISSN): 17501326.
The best quartile for the Molecular Neurodegeneration is Q1 (2022).
The Molecular Neurodegeneration coverage history can be summarized as follows: 2006-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 22945 | De Gruyter Mouton | 15 | 0.19 |
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Journal of Competition Law and Economics | journal | 14815 | Oxford University Press | 29 | 0.72 |
| Socialism and Democracy | journal | 26162 | Taylor and Francis Ltd. | 17 | 0.09 |
| Sapporo Medical Journal | journal | 20468 | Cancer Research Institute, Sapporo Medical University | 3 | 0.00 |
| Journal des Professionnels de l'Enfance | journal | 27577 | TPMA | 2 | 0.00 |
| European Journal of Cancer, Supplement | journal | 9063 | Elsevier Ltd. | 28 | 1.93 |
| International Journal of Pest Management | journal | 13393 | Taylor and Francis Ltd. | 50 | 1.50 |
| Agroalimentaria | journal | 19317 | Centro de Investigaciones Agroalimentarias (CIAAL- | 8 | 0.20 |
| Physica Status Solidi - Rapid Research Letters | journal | 6699 | Wiley-VCH Verlag | 76 | 2.77 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 13.63 |
| 2021 | 16.76 |
| 2020 | 12.10 |
| 2019 | 9.31 |
| 2018 | 8.21 |
| 2017 | 6.78 |
| 2016 | 7.32 |
| 2015 | 6.85 |
| 2014 | 7.01 |
